Search | Clinical Trials Finder

Conditions: Abdominal MRI
Interventions: Respiratory-triggered T1w DISCO LAVA; Device
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Psychological Trauma, Historical, Discrimination, Racial, Emotion Regulation, Social Interaction, Hypervigilance, Anxiety
Interventions: social support; Behavioral
Lead sponsor: University of Nevada, Reno; Other
Eligibility: 18 Years to 65 Years
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Reno, Nevada

Conditions: Cesarean Section Complications, Cesarean Wound; Dehiscence, Cesarean Wound Disruption
Interventions: PICO Negative Pressure Wound Therapy, Standard Dressing; Device
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 153 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: New Hyde Park, New York

Conditions: Interstitial Lung Disease
Interventions: Hyperpolarized 129Xenon Gas; Drug
Lead sponsor: Bastiaan Driehuys; Other
Eligibility: 18 Years and older
Enrollment: 445 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2030
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Brain Tumors, Leukemia, Sarcomas, Neuroblastoma, Lymphoma, Hodgkins Disease
Interventions: Aromatherapy Scented Wand, Placebo wand; Other
Lead sponsor: Albert Einstein College of Medicine; Other
Eligibility: 7 Years to 21 Years
Enrollment: 132 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Preterm, Parent-Child Relations, Parents, Development, Infant, Sensory Integration Dysfunction
Interventions: SENSE multisensory program, Monitored standard of care; Behavioral
Lead sponsor: University of Southern California; Other
Eligibility: 1 Day to 7 Days
Enrollment: 215 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Upper Limb Rehabilitation, Stroke
Interventions: Cooking In the Kitchen; Device
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Satisfaction
Interventions: Secondary Mentor, Career Development Resources; Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: Not listed
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Asthma
Interventions: FF/UMEC/VI (100/31.25/25) mcg, FF/UMEC/VI (100/62.5/25) mcg, FF/UMEC/VI (200/31.25/25) mcg, FF/UMEC/VI (200/62.5/25) mcg, FF/VI (100/25) mcg, FF/VI (200/25) mcg, Fluticasone/salmeterol (FSC), Albuterol/salbutamol, ELLIPTA DPI, DISKUS DPI, METERED-DOSE INHALER (MDI); Drug · Device
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years and older
Enrollment: 2,436 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 99
States / cities: Birmingham, Alabama • Mobile, Alabama • Montgomery, Alabama + 89 more

Conditions: Psychosis, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders, Schizoaffective Disorder
Interventions: Computerized Cognitive Training; Device
Lead sponsor: University of Minnesota; Other
Eligibility: 15 Years to 45 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Secondary Acute Myeloid Leukemia
Interventions: Venetoclax, FLAG or CLAG Protocol; Drug
Lead sponsor: University of Michigan Rogel Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Fibromyalgia
Interventions: Isometric Exercise; Other
Lead sponsor: Marquette University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 43 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Diabetes Mellitus, Type 2
Interventions: 4 mm x 32G pen needle (Nano), 8mm x 31G pen needle (Short); Device
Lead sponsor: Becton, Dickinson and Company; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011
U.S. locations: 2
States / cities: Minneapolis, Minnesota • Berlin, New Jersey

Conditions: Pancreas Cancer
Interventions: Biofeedback, Active Breathing Control Technique; Behavioral
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Other
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: HCC, Hepatocellular Carcinoma, Liver Cancer, Hepatic Neoplasm, Primary Liver Cancer, Liver Neoplasm
Interventions: Lumason, Sonazoid; Diagnostic Test
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Rheumatic Disease
Interventions: Methotrexate, Sulfasalazine, Hydroxychloroquine, Leflunomide, Azathioprine, Mycophenolate, Cyclosporine, Tacrolimus, Etanercept, Adalimumab, Golimumab, Certolizumab, Infliximab, Rituximab, Belimumab, Tocilizumab, Anakinra, Canakinumab, Abatacept, Secukinumab, Ixekizumab, Bimekizumab, Ustekinumab, Guselkumab, Risankizumab, Tofacitinib, Upadacitinib; Drug · Biological
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Encopresis, ASD
Interventions: Glycerin Suppository, Behavioral strategies; Drug · Behavioral
Lead sponsor: Emory University; Other
Eligibility: 5 Years to 12 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Medical Abortion
Interventions: Mifepristone + 2 doses of misoprostol 800 mcg; Drug
Lead sponsor: Gynuity Health Projects; Other
Eligibility: 11 Years to 55 Years · Female only
Enrollment: 23 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 6
States / cities: Hilo, Hawaii • Honolulu, Hawaii • Saint Paul, Minnesota + 3 more

Conditions: Hepatocellular Carcinoma
Interventions: liver biopsy, free-breathing MRI; Procedure · Device
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: 18 Years to 100 Years
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
Interventions: 4 mm x 32G Pen Needle, 8mm x 31G Pen Needle, 12.7mm x 29G Pen Needle; Device
Lead sponsor: Becton, Dickinson and Company; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 293 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 10
States / cities: Escondido, California • Atlanta, Georgia • Springfield, Illinois + 7 more

Conditions: Stroke, Acute
Interventions: Training, Vagus Nerve Stimulation, Sham Stimulation; Other
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years to 75 Years
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Stress, Acute Stress Reaction, Breathing Techniques, Cognitive Performance
Interventions: Box Breathing, Prolonged Exhalation, Normal Breathing; Other
Lead sponsor: Texas State University; Other
Eligibility: 18 Years to 39 Years
Enrollment: 66 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: San Marcos, Texas

Conditions: Lung Cancer, Left Sided Breast Cancer
Interventions: Continuous Positive Airway Pressure, Deep inspiratory breath hold, Free Breath; Device · Other
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Long-COVID, PASC, Long COVID Syndrome
Interventions: Osteopathic Manipulative Therapy Long-COVID protocol, Osteopathic Manipulative Therapy NOT Long-COVID treatment protocol; Other
Lead sponsor: University of Louisville; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Louisville, Kentucky

Search by objective public record fields.

Single Breath Hold Abdominal MRI

The Social Regulation of Threat-related Vigilance and Arousal

PICO Negative Pressure Wound Therapy in Obese Women Undergoing Elective Cesarean Delivery.

Hyperpolarized 129Xe MRI for Imaging Pulmonary Function

A Randomized Trial of The Effectiveness of Aromatherapy on Chemotherapy Induced Nausea and Vomiting in Children With Cancer

Sensory Optimization of the Hospital Environment

Activities of Daily Living (ADL) Virtual Reality (VR) for Acquired Brain Injury (ABI) Upper-Limb Rehabilitation

Secondary Mentoring Program Evaluation

A Phase III Parallel Group Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination (FDC) of Fluticasone Furoate+Umeclidinium Bromide+Vilanterol (FF/UMEC/VI) With the FDC of FF/VI in Subjects With Inadequately Controlled Asthma

State Representation in Early Psychosis - Project 4

A Proof of Concept Pilot Study of the Addition of Venetoclax to Standard Remission Induction Chemotherapy Fludarabine or Cladrabine, Cytarabine, and Granulocyte Colony Stimulating Factor (G-CSF) (FLAG or CLAG) for Frontline Therapy of Secondary Acute Myeloid Leukemia

Isometric Exercise and Endogenous Pain Inhibition

Evaluation of a 4mmx32G Pen Needle for Injection of Basal Insulin Doses Above 40 Units

Breath-Hold Technique for Pancreatic Stereotactic Body Radiation Therapy (SBRT) Patients

Y-90 Treatment Response Using Transarterial Radioembolization

Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty

Comprehensive Toileting Program

Mifepristone and Two Doses of Misoprostol for Abortion at 11&12 Weeks

Assessment of Novel MRI Quantification Free Breathing Technique in Evaluation of Liver Lesions

Comparison of Glycemic Control in Obese Diabetics Using Three Different Pen Needles

VNS-supplemented Motor Retraining After Stroke

The Effect of Breathing on Cognitive Performance and Stress

A Prospective Study to Evaluate Continuous Positive Airway Pressure Devices to Reduce Pulmonary Dose

Osteopathic Manipulative Therapy Effects on Post-Acute Sequelae of COVID-19 (PASC) or Long COVID